Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 11, 1999, Pages 2683-2689

  Andrews, Anthony ^a   Balciunaite, Egle ^b   Leong, Fee Lai ^b   Tallquist, Michelle ^c   Soriano, Philippe ^c   Refojo, Miguel ^b   Kazlauskas, Andrius ^b  

^a Schepens Retina Associates   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANIMAL TISSUE; ARTICLE; DISEASE ACTIVITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RECEPTOR BINDING; VITREORETINOPATHY;

ANIMALS; BLOTTING, WESTERN; CELL LINE; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE EXPRESSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLATELET-DERIVED GROWTH FACTOR; RABBITS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 0032831078     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Campochiaro PA. Mechanisms in ophthalmic disease: pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol. 1997;115:237-241.
2. Glaser BM, Cardin A, Biscoe B. Proliferative vitreoretinopathy: the mechanism of development of vitreoretinal traction. Ophthalmology. 1987;94:327-332.
3. Laqua H, Machemer R. Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80: 602-618.
4. Machemer R, Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:1-23.
5. Ryan, SJ. Traction retinal detachment. XLIX Edward Jackson Memorial Lecture. Am J Ophthalmol. 1993;115:1-20.
6. Baudouin C, Fredj-Reygrobellet D, Gordon WC, et al. Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy. Am J Ophthalmol. 1990;110:593-598.
7. Jerdan JA, Pepose JS, Michels RG, et al. Proliferative vitreoretinopathy membranes. Ophthalmology. 1989;9:801-810.
8. Vinores SA, Campochiaro PA, Conway BP. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci. 1990;31:14-28.
9. Campochiaro PA, Hackett SF, Vinores SA. Growth factors in the retina and retinal pigmented epithelium. Prog Retinal Eye Res. 1996;15:547-567.
10. Chen YS, Hackett SF, Schoenfeld CL, Vinores MA, Vinores SA, Campochiaro PA. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol. 1997;81:919-926.
11. Schneeberger SA, Hjelmeland LM, Tucker RP, Morse LS. Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes. Am J Ophthalmol. 1997;124:447-454.
12. Robbins SG, Mixon RN, Wilson DJ, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci. 1994;35:3649-3663.
13. Campochiaro PA, Hackett SF, Vinores SA, et al. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Clell Sci. 1994;107:2459-2469.
14. Mudhar HS, Pollock RA, Wang C, Stiles CD, Richardson WD. PDGF and its receptors in the developing rodent retina and optic nerve. Development. 1993;118:539-552.
15. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta. 1998; 1378:F79-F113.
16. Rosenkranz S, Kazlauskas A. Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. Growth Factors. 1999;16:201-216.
17. Boström H, Willetts K, Pekny M, et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 1996;85:863-873.
18. Leveen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994;8:1875-1887.
19. Lashkari K, Rahimi N, Kazlauskas A. Hepatocyte growth factor receptor in human retinal pigment epithelial cells: implications in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1999; 40:149-156.
20. Guerrin M, Moukadiri H, Chollet P, Moro F, Datt K, Melecaze F, Plouet J. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol. 1995;164:385-394.
21. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol. 1992;36:373-383.
22. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989;7:980-990.
23. Kazlauskas A, Cooper JA. Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell. 1989;58:1121-1133.
24. Soriano P. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev. 1994;8:1888-1896.
25. Soriano, P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development. 1997;124:2691-2700.
26. Brown M, McCormack M, Zinn KG, Farrell MP, Bikel I, Livingston DM. A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth. J Virol. 1986;60:290-293.
27. Baxter R, Secrist JP, Vaillancourt R, Kazlauskas A. Full activation of the PDGF beta receptor kinase involves multiple events. J Biol Chem. 1998;273:17050-17055.
28. Gelderloos JA, Rosenkranz S, Bazenet C, Kazlauskas A. A role for Src in signal relay by the platelet-derived growth factor alpha receptor. J Biol Chem. 1998;273:5908-5915.
29. Valius M, Bazenet C, Kazlauskas A. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor β subunit and are required for binding of phospholipase Cγ and a 64-kilodalton protein, respectively. Mol Cell Biol. 1993;13:133-143.
30. Blankenship GW, Ibanex-Langlois S. Treatment of myopic macular hole and detachment: intravitreal gas exchange. Ophthalmology. 1987;94:333-336.
31. Thresher RJ, Ehrenberg M, Machemer R. Gas-mediated vitreous compression: an experimental alternative to mechanized vitrectomy. Graefes Arch Clin Exp Ophthalmol. 1984;221:192-198.
32. Fastenberg DM, Diddie KR, Sorgente N, Ryan SJ. A comparison of different cellular inocula in an experimental model of massive periretinal proliferation. Am J Ophthalmol. 1982;93:559-564.
33. Hida T, Chandler DB, Sheta SM. Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye. Graefes Arch Clin Exp Ophthalmol. 1987;225:303-307.
34. Hitchins CA, Grierson I, Hiscott PS. The effects of injections of cultured fibroblasts into the rabbit vitreous. Graefes Arch Clin Exp Ophthalmol. 1985;223:237-249.
35. Pinon RM, Pastor JC, Saornil MA, et al. Intravitreal and subretinal proliferation induced by platelet-rich plasma injection in rabbits. Curr Eye Res. 1992;11:1047-1055.
36. Yang C-M, Olsen KR, Hernandez E, Cousins SW. Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1992;230:66-71.
37. Kazlauskas A, Bowen-Pope DF, Seifert R, Hart CE, Cooper JA. Different effects of homo- and heterodimers of platelet-derived growth factor A and B chains on human and mouse fibroblasts. EMBO J. 1988;7:3727-3735.
38. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268:14553-14556.
39. Beckmann MP, Betsholtz C, Heldin C-H, et al. Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science. 1988;241:1346-1349.
40. Heidaran MA, Beeler JF, Yu J-C, et al. Differences in substrate specificities of α and β platelet-derived growth factor (PDGF) receptors. J Biol Chem. 1993;268:9287-9295.
41. Uren A, Yu JC, Li W, et al. Identification of a domain within the carboxyl-terminal region of the beta platelet-derived growth factor (PDGF) receptor that mediates the high transforming activity of PDGF. J Biol Chem. 1996;271:11051-11054.
42. Nakagawa M, Refojo MF, Marin JF, Doi M, Tolentino FI. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1995;36:2388-2395.
43. Velhagen KH, Druegg A, Rieck P. [In Process Citation]. Ophthalmologe. 1999;96:77-81.
44. Bowen-Pope DF, Ross R. The platelet-derived growth factor receptor. Methods Enzymol. 1984;109:69-100.
45. Lutty GA, Merges C, Threlkeld AB, Crone S, McLeod DS. Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid. Invest Ophthalmol Vis Sci. 1993;34:477-487.
46. Seifert RA, Coats SA, Raines EW, Ross R, Bowen-Pope DF. Platelet-derived growth factor (PDGF) receptor α-subunit mutant and reconstituted cell lines demonstrate that transforming growth factor-β can be mitogenic through PDGF A-chain-dependent and -independent pathways. J Biol Chem. 1994;269:13951-13955.
47. DeMali K, Kazlauskas A. Activation of Src family members is not required for role for PDGF beta receptor to initiate mitogenesis. Mol Cell Biol. 1998;18:2014-2022.
48. DeMali K, Kazlauskas A. Multiple roles for Src in PDGF signaling. Exp Cell Res. In press.
49. Rosenkranz S, Ikuno Y, Leong FL, Kazlauskas A. Src family members act through Cbl to negatively regulate PDGF alpha receptor-dependent signaling and disease progression. In press.
50. Valius M, Kazlauskas A. Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell. 1993;73:321-334.